
Consumer Staples / Healthcare · BSE
Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and nutraceutical products across multiple dosage forms such as tablets, capsules, oral liquids, powders, oils, and external applications including balms, creams, and gels, operating as a Contract Development and Manufacturing Organization (CDMO) for both domestic and international markets including Sri Lanka, Singapore, and the USA. The company blends classical Ayurvedic formulations with modern nutraceutical science to address wellness segments such as liver care, women’s health, bone and joint health, cognitive support, and respiratory health, with its revenue primarily driven by domestic sales and merchant exports on a loan license basis, along with a growing contribution from direct exports. It operates a 10,763 sq. ft. manufacturing facility in Gujarat equipped with modern infrastructure, multiple air handling units, segregated processing areas, and quality control systems, and holds certifications including GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, Halal, and FSSAI.
Price Band
₹122 – ₹129
Issue Size
₹24.77 Cr
Lot Size
1000 shares
GMP
+20.9%
Est. Listing
₹156
at current GMP
Subscribed
1.91x
overall
Open
28 Jan 2026
Close
30 Jan 2026
Allotment
2 Feb 2026
Refund
3 Feb 2026
Demat Credit
4 Feb 2026
Listing
4 Feb 2026
Overall Subscription
1.91x
Total Demand
QIB Multiplier
1.01x
Institutions & Funds
NII / HNI
2.42x
High Net-Worth
Retail (RII)
2.19x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 364,000 | 367,000 | 1.01x |
| NIB | 276,000 | 669,000 | 2.42x |
| HNIs(10L +) | 184,000 | 455,000 | 2.47x |
| HNIs (2-10L) | 92,000 | 214,000 | 2.33x |
| RETAIL | 640,000 | 1,404,000 | 2.19x |
| Total | 1,556,000 | 3,109,000 | 1.91x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| QIB | — | 2 | 0.00x |
| NIB | — | 107 | 0.00x |
| RETAIL | 320 | 702 | 2.19x |
| HNIs(10L +) | 61 | 45 | 0.74x |
| HNIs (2-10L) | 31 | 62 | 2.00x |
| Total Applications | 412 | 918 | 2.23x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Accretion Nutraveda Limited is bringing an initial public offering (IPO) in the Consumer Staples / Healthcare sector with an aggregate issue size of ₹24.77 Crores. The shares are offered at a price band of ₹122 to ₹129 per equity share on BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1000 shares (approx. ₹1,29,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2026-02-04, while un-allotted funds or UPI block mandates will be released on 2026-02-03.
The latest Grey Market Premium (GMP) for Accretion Nutraveda Limited IPO is ₹27 per equity share. Based on the upper price band of ₹122 to ₹129 per equity share, the estimated listing price is ₹156 (+20.9% expected listing gain).
With a lot size of 1000 shares and current GMP of ₹27, the expected profit per application lot is approx ₹27,000 (+20.9% gain). Minimum application cost is approx ₹1,29,000.
The Accretion Nutraveda Limited IPO aggregate issue size is ₹24.77 Crores with an equity price band set at ₹122 to ₹129 per equity share. The retail lot size is 1000 shares requiring a minimum capital outlay of approx. ₹1,29,000.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 1.91x (Retail: 2.19x, QIB: 1.01x, NII: 2.42x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2026-02-02. Investors can verify status using PAN card or application number.
Accretion Nutraveda Limited shares are scheduled to list on BSE on 2026-02-04.